CFF Supports Phase 1/2 of Phage Therapy for P. Aeruginosa InfectionsBiomX has been given up to $5 million to support a clinical trial of BX004, a phage therapy to fight Pseudomonas aeruginosa infections in people with#Cystic Fibrosis·disorders.solutions·Jan 8, 2022CFF Supports Phase 1/2 of Phage Therapy for P. Aeruginosa Infections